Loading…
Lobbying Spend
—
Filings
25
Firms Hired
1
Active Period
2017–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021
2022 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to affordability, essential medicine manufacturing, and pharmaceuticals. General issues related to H.R. 2853, the BLOCKING Act of 2021. Issues related to the Inflation Reduction Act (Public Law 117-169), focusing on pharmaceutical provisions.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2853
Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021
2022 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to affordability, essential medicine manufacturing and pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. Issues related to pharmaceutical provisions in H.R. 5376, the Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2853
Inflation Reduction Act of 2022
2022 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to affordability, essential medicine manufacturing and pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. Issues related to pharmaceutical provisions in H.R. 5376, the Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021
2022 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to affordability, essential medicine manufacturing and pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. Issues related to pharmaceutical provisions in H.R. 5376, the Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2853
Inflation Reduction Act of 2022
2022 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to affordability, essential medicine manufacturing and pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. Issues related to pharmaceutical provisions in H.R. 5376, the Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021
2021 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to affordability, essential medicine manufacturing and pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. Issues related to pharmaceutical provisions in H.R. 5376, the Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2853
Inflation Reduction Act of 2022
2021 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to affordability, essential medicine manufacturing and pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. Issues related to pharmaceutical provisions in H.R. 5376, the Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021
2021 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2853
American Rescue Plan Act of 2021
2021 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 1319, the American Rescue Plan.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1319
American Rescue Plan Act of 2021
2021 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the implementation of H.R. 1319, the American Rescue Plan. Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1319
Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021
2021 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the implementation of H.R. 1319, the American Rescue Plan. Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2853
American Rescue Plan Act of 2021
2021 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicaid CPI Penalty. Issues related to H.R. 1319, the American Rescue Plan.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1319
American Rescue Plan Act of 2021
2021 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 1319, the American Rescue Plan. Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1319
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. S. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing. Issues related to H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021, including provisions affecting the generic drug industry. Issues related to H.R. 938, BLOCKING Act of 2019.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 133
The Heroes Act
2020 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions. Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6800
The Heroes Act
2020 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. S. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing. Issues related to H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021, including provisions affecting the generic drug industry. Issues related to H.R. 938, BLOCKING Act of 2019.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6800
Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions. Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 748
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. S. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing. Issues related to H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021, including provisions affecting the generic drug industry. Issues related to H.R. 938, BLOCKING Act of 2019.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 748
BLOCKING Act of 2019
2020 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. S. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing. Issues related to H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021, including provisions affecting the generic drug industry. Issues related to H.R. 938, BLOCKING Act of 2019.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 938
The Heroes Act
2020 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. S. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6800
The Heroes Act
2020 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions. Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6800
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. S. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 748
Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions. Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 748
Protecting Consumer Access to Generic Drugs Act of 2019
2020 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the abuses of the patent system, extensions of drug exclusivity, pay-for-delay, and the inter partes review (IPR) process, including H. R. 1499, the Protecting Consumer Access to Generic Drugs Ace of 2019, and H. R. 938, the BLOCKING Act of 2019. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act). Issues related to H.R. 6800, the HEROES Act.
Client expense: — · Firm income: $50,000
Matched citations: H. R. 1499
The Heroes Act
2020 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions. Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6800
Source: Senate LDA